Mindfulness interventions show mixed effects on breathlessness and pulmonary function in lung cancer patients

This meta-analysis examined the effects of mindfulness-based interventions in patients with lung cancer, pooling data from 14 randomized controlled trials involving 1,190 participants. The study setting was not reported, but the population specifically comprised individuals diagnosed with lung cancer. The intervention consisted of mindfulness-based approaches, though specific protocols, durations, or dosing details were not provided. The comparator was control conditions, which were not further specified in the available data.

The primary outcome was breathlessness, measured through self-reported assessments. The analysis found no significant improvement in breathlessness with mindfulness interventions compared to controls, with a standardized mean difference (SMD) of -0.44 (95% CI: -0.92 to 0.05). This indicates the effect did not reach statistical significance, as the confidence interval crosses zero.

Key secondary outcomes showed more positive results. For pulmonary function, significant improvements were observed across multiple measures: vital capacity increased by a mean difference (MD) of 0.44 L (95% CI: 0.18-0.70), peak expiratory flow improved by MD = 14.72 L/s (95% CI: 6.14-23.30), forced expiratory volume in one second (FEV) increased by MD = 0.49 L (95% CI: 0.17-0.81), forced vital capacity (FVC) improved by MD = 0.55 L (95% CI: 0.28-0.83), and FEV/FVC ratio increased by MD = 8.02% (95% CI: 5.77-10.28). Psychological outcomes also showed significant benefits, with depressive symptoms reduced (SMD = -1.28, 95% CI: -2.25 to -0.31) and anxiety decreased (SMD = -1.54, 95% CI: -2.34 to -0.74).

Subgroup analysis revealed that when mindfulness was combined with respiratory function interventions, breathlessness showed significant improvement (SMD = -0.53, 95% CI: -0.86 to -0.21). This combination also enhanced FEV (MD = 0.28 L, 95% CI: 0.17-0.39) and FVC (MD = 1.29, 95% CI: 0.64-1.95) compared to respiratory function interventions alone.

Safety and tolerability data were not reported in this meta-analysis. No information was provided regarding adverse events, serious adverse events, discontinuation rates, or overall tolerability of the mindfulness interventions.

Compared to prior research in lung cancer supportive care, these findings align with mixed evidence on non-pharmacological interventions for breathlessness management. While some studies have shown benefits for psychological interventions, the lack of significant improvement in the primary outcome of breathlessness contrasts with some previous smaller trials that reported positive effects. The pulmonary function improvements are notable given that lung cancer patients often experience respiratory compromise, though the clinical significance of these changes requires further evaluation.

Methodological limitations include the need for further high-quality RCTs to determine optimal intervention dosages and long-term impact. The analysis pooled results from multiple studies, which may have varied in intervention protocols, control conditions, and outcome measurement methods. The setting and follow-up duration were not reported, limiting contextual understanding. The absence of safety data represents another significant limitation for clinical application.

Clinical implications suggest that mindfulness-based interventions may offer benefits for pulmonary function and psychological well-being in lung cancer patients, though they did not demonstrate statistically significant improvement in self-reported breathlessness. The subgroup analysis indicating that combining mindfulness with respiratory function training may offer additional benefits for alleviating breathlessness warrants consideration in clinical practice. However, these findings should be interpreted cautiously given the methodological limitations and lack of safety data.

Unanswered questions include the optimal dosing and duration of mindfulness interventions for lung cancer patients, long-term effects on both pulmonary and psychological outcomes, comparative effectiveness against other non-pharmacological approaches, and safety profiles. The mechanisms through which mindfulness might influence pulmonary function in this population also require further investigation, as do patient factors that might predict better response to these interventions.